Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Locally Advanced Thyroid Gland Papillary Carcinoma

Tundra lists 1 Locally Advanced Thyroid Gland Papillary Carcinoma clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06959641

XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer

This phase II trial tests how well XL092 works for the treatment of patients with differentiated thyroid cancer that has not responded to previous treatment with radioiodine (radioiodine refractory) and that has spread to nearby tissue or lymph nodes (locally advanced) or that has spread from where it first started (primary site) to other places in the body (metastatic). XL092 is in a class of medications called tyrosine kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply, which may help keep cancer cells from growing.

Gender: All

Ages: 18 Years - Any

Updated: 2025-06-11

1 state

Locally Advanced Differentiated Thyroid Gland Carcinoma

Locally Advanced Poorly Differentiated Thyroid Gland Carcinoma

Locally Advanced Thyroid Gland Follicular Carcinoma

+18